ALCAM, Activated Leukocyte Cell Adhesion Molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis

Anticancer Research

Volumn 30, Issue 4, 2010, Pages 1163-1168

  Davies, Simon ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

ALCAM; Bone metastasis; Breast cancer; CD166; Cell adhesion

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; MATRIX PROTEIN; SCATTER FACTOR;

ANTIGEN EXPRESSION; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; ELECTRIC CELL SUBSTRATE IMPEDANCE SENSING; GENE SEQUENCE; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; SOLID TUMOR; TRANSGENE; WILD TYPE;

ANTIGENS, CD; BONE NEOPLASMS; BREAST NEOPLASMS; CELL ADHESION; CELL ADHESION MOLECULES, NEURONAL; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; EXTRACELLULAR MATRIX; FEMALE; FETAL PROTEINS; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM INVASIVENESS; RNA, MESSENGER; TRANSFECTION;

EID: 77953795909     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Bowen MA, DD Patel, Li X, Modrell B, Malacko AR, Wang WC, Marquardt H, Neubauer M, Pesando JM, Francke U, Haynes BF and Aruffo A: Cloning, mapping, and characterization of activated leukocyte-cell adhesion molecule (ALCAM), a CD6 ligand. J Exp Med 181: 2213-2220, 1995.
2. Uchida N, Yang Z, Combs J, Pourquie O, Nguyen M, Ramanathan R, Fu J, Welply A, Chen S, Weddell G, Sharma AK, Leiby KR, Karagogeos D, Hill B, Humeau L, Stallcup WB, Hoffman R, Tsukamoto AS, Gearing DP and Peault B: The characterization, molecular cloning, and expression of a novel hematopoietic cell antigen from CD34- human bone marrow cells. Blood 89: 2706-2716, 1997.
3. Ikeda K and Quertermous T: Molecular isolation and characterization of a soluble isoform of activated leukocyte cell adhesion molecule that modulates endothelial cell function. J Biol Chem 279: 55315-55323, 2004
4. Burns F, von Kannen S, Guy L, Raper J, Kamholz J and Chang S: DM-GRASP, a novel immunoglobulin superfamily axonal surface protein that supports neurite extension. Neuron 7: 209-220, 1991.
5. Peduzzi J, Irwin M and Geisert E: Distribution and characteristics of a 90 kDa protein, KG-CAM in the rat CNS. Brain Res 640: 296-307, 1994.
6. van Kempen LC, Nelissen JM, Degen WG, Torensma R, Weidle UH, Bloemers HP, Figdor CG and Swart GW: Molecular basis for the hemophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction. J Biol Chem 276: 25783-25790, 2001. (Pubitemid 33730632)
7. Hassan, NJ, Barclay AN and Brown MH: Frontline: Optimal T cell activation requires the engagement of CD6 and CD166. Eur J Immunol 34: 930-940, 2004.
8. Kristiansen G, Pilarsky C, Wissmann C, Stephan C, Weissbach L, Loy V, Loening S, Dietel M and Rosenthal A: ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate 54: 34-43, 2003.
9. Weichert W, Knosel T, Bellach, J, Dieal M and Kistianse G: ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival. J Clin Pathol 57: 1160-1164, 2004.
10. Verma A, Shukla NK, Deo SVS, Gupta SD and Ralham R: MEMD/ALCAM: A potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma. Oncology 68: 463-470, 2005.
11. Ohneda O, Ohneda K, Arai F, Lee J, Miyamoto T, Fukushima Y, Dowbenko D, Lasky LA and Suda T: ALCAM (CD166): its role in hematopoietic and endothelial development. Blood 98: 2134-2142, 2001.
12. Arai F, Ohneda O, Miyamoto T, Zhang X and Suda T: Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. J Exp Med 195: 1549-1563, 2002.
13. King JA, Ofori-Acquah SF, Stevens T, Al-Mehdi AB, Fodstad O and Jiang WG: Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res 6: 478-487, 2004.
14. Jezierska A, Matysiak W and Motyl T: ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy. Med Sci Monit 12: 263-273, 2006.
15. Davies SR, Dent C, Watkins G, King JA, Mokbel K and Jiang WG: Expression of the cell to cell adhesion molecule, ALCAM, in breast cancer patients and the potential link with skeletal metastasis. Oncology Rep 19: 555-561, 2008. (Pubitemid 351176120)
16. Davies G, Jiang WG and Mason MD: Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells. J Urol 163: 985-992, 2000. (Pubitemid 30091675)
17. Jiang WG, Davies G, Martin TA, Parcc C, Watkins G, Mason MD, Mokbel K and Mansel RE: Molecular targeting of matrilysin and its impact on tumour growth in vivo, the potential implications in breast cancer therapy. Clin Cancer Res 11: 6012-6019, 2005.
18. Jiang WG, Grimshaw D, Lane J, Martin TA, Parr C, Davies G, Laterra J and Mansel RE: Retroviral hammerhead transgenes to cMET and HGF/SF inhibited growth of breast tumour, induced by fibroblasts. Clin Cancer Res 9: 4274-4281, 2003.
19. Jiang WG, Ablin RJ, Kynaston HG and Mason MD: The Prostate Transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway. Microvascular Res 77: 150-157, 2009.
20. Jiang WG, Hiscox S, Hallett MB, Horrobin DF, Mansel RE and Puntis MCA: Regulation of the expression of E-cadherin on human cancer cells by gamma linolenic acid. Cancer Res 55: 5043-5048, 1995.
21. Giaever I and Keese CR: Monitoring fibroblast behavior in tissue culture with an applied electric field. Proc Natl Acad Sci USA 81: 3761-3764, 1984. (Pubitemid 14087798)
22. Giaever I and Keese CR: Micromotion of mammalian cells measured electrically. Proc Natl Acad Sci USA 88: 7896-7900, 1991. (Pubitemid 21915262)
23. Jiang WG, Martin TA, Russell-Lewis J, Ye L, Douglas-Jones A and Mansel RE: Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome. Mol Cancer 7: 71, 2008.